Merrimack Pharmaceuticals misses by $0.04, misses on revenue

|About: Merrimack Pharmaceuticals (MACK)|By:, SA News Editor

Merrimack Pharmaceuticals (MACK): Q4 EPS of -$0.33 misses by $0.04.

Revenue of $7.82M (-44.9% Y/Y) misses by $5.65M.